GlucoTrack, Inc.

GCTK Healthcare Medical Instruments & Supplies

In the quarter to June 2026, EPS grew 92.1%, free cash flow grew 3.42% and total debt rose 777.8%, each against the same quarter a year earlier.

0.73 0.10 −12.05%
Market cap
$840.0K
P/E
0.0×
Fwd P/E
−17.8×
Dividend yield
—
F-score
3/9
Altman Z
26019048.63
Beneish M
2.40
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
— — — —

+8 more quarters

EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
0.46 0.85 1.61 1.53
Net Debt/EBITDA
(0.25) 0.09 1.19 1.08
Debt/Equity
(1.11) (4.19) 1.21 1.18
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(10.82) (37.04) (95.56) (78.13)
Book value per Share
(5.21) (7.79) 68.31 45.85
Free Cash Flow
(3.62) (4.05) (3.96) (4.69)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates